Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 257Thoracic 12Gastrointestinal 8Other 6Sarcoma 5Gynecologic 4CNS 4Genitourinary 3Other solid neoplasm 2Other neoplasm 2Endocrine 2Dermatologic 2Breast 2Lymphoid 1Classical hematology 1

Conditions

Anemia 4Uterine Cervical Neoplasms 2Lung Neoplasms 2Drug-Related Side Effects and Adverse Reactions 2Carcinoma, Non-Small-Cell Lung 2Thrombocytopenia 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma 1Radiation Injuries 1Neutropenia 1Neoplasms 1Head and Neck Neoplasms 1Fanconi Anemia 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

apixaban 1Radiotherapy 1Gemcitabine 1Epoetin Alfa 1Enoxaparin 1Cisplatin 1ALT-836 1ACE-011 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Head and Neck Neoplasms × Cisplatin × Classical hematology × Clear all
NCT00004917 2020-10-22

Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer

Radiation Therapy Oncology Group

Phase 3 Completed
Classical hematologyHead & Neck

Squamous Cell Carcinoma of Head and Neck, Anemia, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡